✦ LIBER ✦

Randomised study of anastrozole versus tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women

✍ Scribed by I. Vergote; J. Bonneterre; B. Thürlimann; J. Robertson; M. Krzakowski; L. Mauriac; L. Koralewski; A. Webster; M. Steinberg; M. von Euler

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-effectiveness of anastrozole versus

✍ W.Robert Simons; David Jones; Aman Buzdar 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 175 KB

Efficacy of tamoxifen following anastroz

✍ B. Thürlimann; J.F.R. Robertson; J.M. Nabholtz; A. Buzdar; J. Bonneterre 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 247 KB

PCN5: FIRST-LINE THERAPY FOR ADVANCED BR

✍ M Marchetti; N Liberato; G Barosi 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 52 KB

Fulvestrant versus anastrozole as second

✍ I Vergote 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 68 KB

A stochastic economic evaluation of Letr

✍ J.D. Karnon; T.E.D. Jones 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 159 KB

‘Arimidex’ (anastrozole) versus tamoxife

✍ Aman U. Buzdar 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 122 KB